Kyle Salyers
About Kyle Salyers
Kyle Salyers serves as the Chief Strategy Officer at Health Catalyst, where he has held various roles since 2013. He has extensive experience in corporate development and investment across multiple healthcare companies.
Current Role at Health Catalyst
Kyle Salyers serves as the Chief Strategy Officer (CSO) at Health Catalyst, a position he has held since 2023. He is also the Senior Vice President of Corporate Development, a role he has maintained since 2014. His work is based in both Indianapolis and Salt Lake City. In addition to these roles, he has been an investor at Health Catalyst since 2013.
Investment Experience
Kyle Salyers has extensive investment experience across multiple organizations. He has been an investor at Noxilizer since 2011, at par8o since 2013, and at NeoChord since 2007. Additionally, he serves as an investor and board observer at Nico Neuro and Spine, a role he has held since 2008. His investment activities reflect a long-term commitment to supporting innovative healthcare solutions.
Educational Background
Kyle Salyers studied at Harvard Business School, where he completed an Executive Education Certificate in Corporate Governance in 2009. He also earned an MBA from the University of Notre Dame - Mendoza College of Business from 2007 to 2009. Earlier, he obtained a BA in Sociology and Economics from DePauw University, studying there from 1992 to 1996.
Previous Leadership Roles
Before his current roles, Kyle Salyers co-founded CHV Capital and served as its Managing Director at Indiana University Health from 2007 to 2014. He also worked as an investor and director at PerfectServe, Inc. from 2011 to 2018. These positions contributed to his expertise in corporate development and strategic planning.